Multiple myeloma counts among relatively rare diseases. In the Czech Republic, about 400 patients are diagnosed each year. Multiple myeloma remains an incurable hematological malignancy, however, given the current scope of the novel medicines, it is successfully treatable. The benefits of the treatment include prolongation of patients’ life. More and more emphasis is placed on the patients’ quality of life which is tightly connected with timely diagnosis and therapy initiation before any serious impairment occurs.
In case a patient presents with the above-described symptoms, it is necessary to consider the multiple myeloma diagnosis, especially in patients aged over 50 years. However, cases of myeloma disease in 30-year-olds have also been reported.
© 2011 Project CRAB, All Rights Reserved